In mice, ZIKV is incapable of blocking the type I IFN response and viral replication following peripheral infection is limited; hence, the initial approach to study the infection in this species was to disrupt the type I IFN signaling pathway by either genetic manipulation or administration of IFNAR blocking Abs prior to infection (16–18). The gene discussed is IFNAR1; the disease is infection.